Akzo Nobel N.V. AKZA.AS
Composite 57/100; the shares have moved about 48% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Quality ranks 49/100 — a slight mark against it.
Income ranks 75/100 — a strong point in its favour. Valuation ranks 64/100 — a moderate point in its favour. Momentum ranks 60/100 — a slight point in its favour.
Quality ranks 49/100 — a slight mark against it.
What the company does Akzo Nobel N.V. (AKZA.AS) is a global leader in paints and coatings, operating through Decorative Paints and Performance Coatings segments. Its brands include Dulux, International, and Interpon, serving industries like automotive, aerospace, and construction.
Key financials Akzo reports ROE 14.1%, ROA 3.3%, and ROCE 10.8%. Margins stand at gross 40.3%, operating 10.8%, and net 6.4%. Revenue growth is -1.4% while EPS growth is 12.5%. Debt/Equity is 1.31 with net debt/EBITDA at 2.93.
Stock health The stock shows strong momentum: +21.81% over 3 months, +6.07% over 6 months, and +16.78% over 12 months. RSI(14) is 60.90, indicating bullish momentum. Income pillar score is high at 79.7, reflecting a 2.7% dividend yield.
Price vs fair value The stock trades at a **PREMIUM of 4.60%** versus our fair-value estimate of 57.96 and at a **discount of 4.92%** versus the 12-month target of 63.75. - Valuation metrics (P/E 16.14, EV/EBITDA 8.26) are near long-term averages (Sideravia Valuation 69.0). - Growth pillar score is low at 48.4, with revenue declining -1.4%. - Momentum is strong (62.4), supporting the premium to fair value.
Looking forward Forward P/E of 15.72 and PEG of 5.88 suggest moderate earnings growth expectations. Analysts (n=16) see 63.75 as a 12-month target, implying ~5% upside. Focus remains on margin recovery and growth initiatives in Performance Coatings.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.